203 related articles for article (PubMed ID: 12717846)
1. Expression of hepatitis C virus hypervariable region 1 and its clinical significance.
Zhang XX; Zhang SY; Liu J; Lu ZM; Wang Y
World J Gastroenterol; 2003 May; 9(5):1003-7. PubMed ID: 12717846
[TBL] [Abstract][Full Text] [Related]
2. The hypervariable region 1 protein of hepatitis C virus broadly reactive with sera of patients with chronic hepatitis C has a similar amino acid sequence with the consensus sequence.
Watanabe K; Yoshioka K; Ito H; Ishigami M; Takagi K; Utsunomiya S; Kobayashi M; Kishimoto H; Yano M; Kakumu S
Virology; 1999 Nov; 264(1):153-8. PubMed ID: 10544140
[TBL] [Abstract][Full Text] [Related]
3. Broadly reactive antibodies to hypervariable region 1 in hepatitis C virus-infected patient sera: relation to viral loads and response to interferon.
Hattori M; Yoshioka K; Aiyama T; Iwata K; Terazawa Y; Ishigami M; Yano M; Kakumu S
Hepatology; 1998 Jun; 27(6):1703-10. PubMed ID: 9620346
[TBL] [Abstract][Full Text] [Related]
4. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment.
Zibert A; Schreier E; Roggendorf M
Virology; 1995 Apr; 208(2):653-61. PubMed ID: 7538251
[TBL] [Abstract][Full Text] [Related]
5. Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C.
Pawlotsky JM; Pellerin M; Bouvier M; Roudot-Thoraval F; Germanidis G; Bastie A; Darthuy F; Rémiré J; Soussy CJ; Dhumeaux D
J Med Virol; 1998 Apr; 54(4):256-64. PubMed ID: 9557291
[TBL] [Abstract][Full Text] [Related]
6. Broadly cross-reactive mimotope of hypervariable region 1 of hepatitis C virus derived from DNA shuffling and screened by phage display library.
Zhang XX; Deng Q; Zhang SY; Liu J; Cai Q; Lu ZM; Wang Y
J Med Virol; 2003 Dec; 71(4):511-7. PubMed ID: 14556263
[TBL] [Abstract][Full Text] [Related]
7. A Novel Approach To Display Structural Proteins of Hepatitis C Virus Quasispecies in Patients Reveals a Key Role of E2 HVR1 in Viral Evolution.
Tong Y; Li Q; Li R; Xu Y; Pan Y; Niu J; Zhong J
J Virol; 2020 Aug; 94(17):. PubMed ID: 32554700
[TBL] [Abstract][Full Text] [Related]
8. Ontogeny of hepatitis C virus (HCV) hypervariable region 1 (HVR1) heterogeneity and HVR1 antibody responses over a 3 year period in a patient infected with HCV type 2b.
Majid A; Jackson P; Lawal Z; Pearson GM; Parker H; Alexander GJ; Allain JP; Petrik J
J Gen Virol; 1999 Feb; 80 ( Pt 2)():317-325. PubMed ID: 10073690
[TBL] [Abstract][Full Text] [Related]
9. Development of a plant-derived subunit vaccine candidate against hepatitis C virus.
Nemchinov LG; Liang TJ; Rifaat MM; Mazyad HM; Hadidi A; Keith JM
Arch Virol; 2000; 145(12):2557-73. PubMed ID: 11205105
[TBL] [Abstract][Full Text] [Related]
10. A possible role of hypervariable region 1 quasispecies in escape of hepatitis C virus particles from neutralization.
Korenaga M; Hino K; Katoh Y; Yamaguchi Y; Okuda M; Yoshioka K; Okita K
J Viral Hepat; 2001 Sep; 8(5):331-40. PubMed ID: 11555190
[TBL] [Abstract][Full Text] [Related]
11. Immune Reactivity of Synthetic Peptides Originated from Hypervariable Region 1 of Hepatitis C Synthetic Consensuses with Egyptian Sera Infected with Hepatitis C Virus Type 4.
Abdel-Fattah M; Charmy R; Tawfik AR
Intervirology; 2015; 58(4):232-41. PubMed ID: 26330263
[TBL] [Abstract][Full Text] [Related]
12. Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants.
Puntoriero G; Meola A; Lahm A; Zucchelli S; Ercole BB; Tafi R; Pezzanera M; Mondelli MU; Cortese R; Tramontano A; Galfre' G; Nicosia A
EMBO J; 1998 Jul; 17(13):3521-33. PubMed ID: 9649423
[TBL] [Abstract][Full Text] [Related]
13. Constrained genomic and conformational variability of the hypervariable region 1 of hepatitis C virus in chronically infected patients.
Hino K; Korenaga M; Orito E; Katoh Y; Yamaguchi Y; Ren F; Kitase A; Satoh Y; Fujiwara D; Okita K
J Viral Hepat; 2002 May; 9(3):194-201. PubMed ID: 12010507
[TBL] [Abstract][Full Text] [Related]
14. Antibodies directed to envelope proteins of hepatitis C virus outside of hypervariable region 1.
Lechner S; Rispeter K; Meisel H; Kraas W; Jung G; Roggendorf M; Zibert A
Virology; 1998 Apr; 243(2):313-21. PubMed ID: 9568031
[TBL] [Abstract][Full Text] [Related]
15. Cross-reactivity of hypervariable region 1 chimera of hepatitis C virus.
Xiu BS; Ling SG; Song XG; Zhang HQ; Chen K; Zhu CX
World J Gastroenterol; 2003 Jun; 9(6):1256-60. PubMed ID: 12800235
[TBL] [Abstract][Full Text] [Related]
16. Network Analysis of the Chronic Hepatitis C Virome Defines Hypervariable Region 1 Evolutionary Phenotypes in the Context of Humoral Immune Responses.
Palmer BA; Schmidt-Martin D; Dimitrova Z; Skums P; Crosbie O; Kenny-Walsh E; Fanning LJ
J Virol; 2015 Dec; 90(7):3318-29. PubMed ID: 26719263
[TBL] [Abstract][Full Text] [Related]
17. Anti-envelope 1 and 2 immune response in chronic hepatitis C patients: effects of hepatitis B virus co-infection and interferon treatment.
Zampino R; Marrone A; Durante Mangoni E; Santarpia L; Sica A; Tripodi MF; Utili R; Ruggiero G; Adinolfi LE
J Med Virol; 2004 May; 73(1):33-7. PubMed ID: 15042645
[TBL] [Abstract][Full Text] [Related]
18. Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine.
Law JLM; Logan M; Wong J; Kundu J; Hockman D; Landi A; Chen C; Crawford K; Wininger M; Johnson J; Mesa Prince C; Dudek E; Mehta N; Tyrrell DL; Houghton M
J Virol; 2018 Jun; 92(11):. PubMed ID: 29540595
[TBL] [Abstract][Full Text] [Related]
19. Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus.
Esumi M; Ahmed M; Zhou YH; Takahashi H; Shikata T
Virology; 1998 Nov; 251(1):158-64. PubMed ID: 9813211
[TBL] [Abstract][Full Text] [Related]
20. Genetic heterogeneity of the envelope 2 gene and eradication of hepatitis C virus after a second course of interferon-alpha.
Boulestin A; Sandres-Sauné K; Payen JL; Alric L; Dubois M; Pasquier C; Vinel JP; Pascal JP; Puel J; Izopet J
J Med Virol; 2002 Oct; 68(2):221-8. PubMed ID: 12210411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
